跳至主要内容
临床试验/NCT04131296
NCT04131296Unknown不适用

Association of Lung Bacteriobiota With Intensive Care Unit Mortality in ARDS Patients: MicroFlu Study

University of Bordeaux3 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2019年12月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
64
试验地点
3
主要终点
Lung bacteriobiota and ICU mortality

研究概览

简要总结

Influenza is a potentially lethal disease still responsible for thousands excess deaths both in Europe and the United States. Despite the use of neuraminidase inhibitors, its treatment is mostly based on symptomatic care. Lung microbiota has been shown to be involved in the immunity against influenza and is correlated with lung inflammation in numerous chronic respiratory diseases. We therefore aim to analyse the correlation between lung bacteriobiota and influenza ICU mortality

详细描述

Influenza is a viral disease which is still responsible for thousands of excess deaths par year both in Europe and in the US. Despite the use of neuraminidase inhibitors, its treatment is mostly based on symptomatic care. As lung microbiota is correlated with lung inflammation in numerous chronic respiratory diseases, we hypothesize that lung microbiota would be correlated with influenza outcomes. In a pilot study, we found that lung bacteriobiota but not mycobiota is associated with influenza ICU mortality. We therefore aim to confirm this correlation between lung bacteriobiota and influenza mortality.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient above 18 year-old admitted to intensive care unit
  • Influenza diagnosis by PCR or rapid diagnostic test

排除标准

  • Guardianship or curatorship
  • Prisoners
  • No health insurance
  • No legal representative

结局指标

主要结局

Lung bacteriobiota and ICU mortality

时间窗: at admission

Comparison of lung bacteriobiota alpha diversity between influenza ICU survivors and non-survivors

次要结局

  • Lung bacteriobiota and ICU mortality(at admission)
  • Lung bacteriobiota and 7-day mortality(at admission)
  • Bacteria and ICU mortality(at admission)
  • Bacteria and 7-day mortality(at admission)
  • ICU mortality based on Shannon index(at admission)

研究者

发起方
University of Bordeaux
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Pauline Esteves

Doctor

University of Bordeaux

研究点 (3)

Loading locations...

相似试验

Lung Bacteriobiota and Influenza Mortality | 临床试验